Table 1 IMGT analysis of the antibody sequence
From: Rapid production of monoclonal antibodies from single mouse B cells against FMDV
NO | Heavy chain | Light chain | ||||
|---|---|---|---|---|---|---|
IGHV | Identity | CDR3 length | IGKV | Identity | CDR3 length | |
4 | 1–2 | 76.5% | 13 | 3–11 | 68.7% | 9 |
15 | 1–2 | 76.4% | 13 | 4–1 | 84.1% | 9 |
31 | 1–2 | 74.4% | 13 | 7–3 | 77.7% | 9 |
33 | 1–2 | 74.4% | 13 | 7–3 | 77.7% | 9 |
34 | 1–2 | 74.4% | 13 | 7–3 | 77.4% | 9 |
39 | 1–2 | 74.4% | 13 | 7–3 | 77.0% | 9 |
49 | 1–2 | 74.4% | 13 | 1–17 | 76.1% | 9 |
55 | 1–2 | 74.4% | 13 | 5–2 | 74.5% | 9 |
56 | 1–2 | 74.4% | 13 | 7–3 | 77.7% | 9 |
57 | 1–2 | 74.4% | 13 | 7–3 | 78.4% | 9 |
58 | 1–2 | 74.4% | 13 | 7–3 | 78.4% | 9 |
63 | 1–2 | 74.4% | 13 | 1–9 | 81.8% | 9 |
71 | 1–2 | 75.8% | 13 | 1–9 | 81.8% | 9 |
76 | 1–2 | 74.4% | 13 | 7–3 | 77.7% | 9 |
82 | 1–2 | 74.4% | 13 | 4–1 | 84.1% | 9 |
109 | 1–2 | 74.4% | 13 | 1–16 | 73.6% | 9 |
114 | 1–2 | 74.4% | 13 | 7–3 | 77.7% | 9 |
119 | 1–2 | 74.4% | 13 | 3–11 | 70.9% | 9 |
121 | 1–2 | 74.4% | 13 | 7–3 | 77.7% | 9 |
123 | 1–2 | 73.8% | 13 | 3–15 | 71.7% | 9 |